Teleflex stock price target raised to $135 from $130 at RBC Capital
Old Republic International Corporation (NYSE:ORI) stock soared to an all-time high, reaching a price level of $37.39. According to InvestingPro analysis, the company appears undervalued, with a GREAT financial health score of 3.0 out of 4.0. This milestone underscores a period of significant growth for the insurance company, reflecting investor confidence and a strong market position. Over the past year, Old Republic’s stock has delivered a remarkable 39.94% return, outpacing many of its industry peers. Trading at an attractive P/E ratio of 11.24 and maintaining dividend payments for 55 consecutive years, the company demonstrates robust financial health and potential for continued upward momentum. This performance highlights the company’s successful strategies and the positive reception of its business initiatives by the market. Discover more insights and 8 additional ProTips for ORI with an InvestingPro subscription.
In other recent news, Old Republic International Corporation reported its fourth-quarter 2024 earnings, which exceeded analysts’ expectations with an earnings per share (EPS) of $0.90, surpassing the forecasted $0.73. The company’s revenue for the quarter was $2 billion, slightly below the $2.06 billion forecast. Despite the revenue miss, the earnings surprise was significant, reflecting effective cost management and strategic initiatives. Raymond (NSE:RYMD) James responded by raising the stock’s price target from $38.00 to $40.00, maintaining an Outperform rating, citing strong performance in the specialty segment as a key factor. Meanwhile, JMP Securities maintained a Market Perform rating on Old Republic, noting the company’s strong underwriting results in both its Title and Specialty Insurance segments. The Title Insurance segment outperformed with a $39 million underwriting result, and the Specialty Insurance segment posted $101 million, both exceeding expectations. Furthermore, Old Republic’s financial strategies, including stable dividends and share repurchases, were highlighted as favorable for the stock’s valuation. Looking ahead, analysts from Raymond James anticipate continued strength in the specialty segment and potential growth from the title segment as the housing market recovers.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.